Author

Adriano Bonaldi

Assembleia Legislativa de São Paulo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:variant calling· 2 Research Focus:benchmarking· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Camila Alves SouzaiD· 2 shared Cristovam Scapulatempo‐NetoiD· 2 shared Darine VillelaiD· 2 shared José Eduardo KrolliD· 2 shared Luiz Gustavo Dufner‐AlmeidaiD· 2 shared Paulo Marques PierryiD· 2 shared Rodrigo Guarischi‐SousaiD· 2 shared Ana Cristina Victorino KrepischiiD· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Camila Alves SouzaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Low-pass whole genome sequencing is a reliable and cost-effective approach for copy number variant analysis in the clinical setting

Patricia C. Mazzonetto, Darine Villela, Silvia Souza da Costa, Ana Cristina Victorino Krepischi, Fernanda Milanezi, Michele Patricia Migliavacca, Paulo Marques Pierry, Adriano Bonaldi, Luiz Gustavo Dufner‐Almeida, Camila Alves Souza, José Eduardo Kroll, Marcelo G. Paula, Rodrigo Guarischi‐Sousa, Cristovam Scapulatempo‐Neto, Carla Rosenberg

This study validates low-pass whole genome sequencing as a reliable and cost-effective method for detecting copy number variants in clinical settings.

Annals of Human Genetics · Oct 9, 2023Peer-reviewedGenetic & Genomic Medicine

HRD-One: CLINICAL VALIDATION AND PERFORMANCE ASSESSMENT. Comparison between Myriad's myChoice(R), SOPHiA GENETICS SOPHiA Homologous Recombination Solution(R) and AmoyDx HRD Focus Panel(R)

Rodrigo Guarischi‐Sousa, José Eduardo Kroll, Adriano Bonaldi, Paulo Marques Pierry, Luiz Gustavo Dufner‐Almeida, Camila Alves Souza, Juliana Santos Silva, Darine Villela, Fabiana Marcelino Meliso, Maria Fernanda Grillo Milanezi, Cristovam Scapulatempo‐Neto, Guilherme Lopes Yamamoto

HRD-One provides a reproducible HRD score with high concordance to myChoice(R) and identifies HRD in ovarian cancer samples with and without BRCA1/2 mutations.

medRxiv · Mar 28, 2023 · PreprintGenetic & Genomic Medicine